| scholarly article | Q13442814 |
| P50 | author | Laura Orsolini | Q60442819 |
| P2093 | author name string | Giovanni Martinotti | |
| Alessandro Valchera | |||
| Gabriella Rapini | |||
| Giampaolo Perna | |||
| Luigi Olivieri | |||
| Michele Fornaro | |||
| Massimo Di Giannantonio | |||
| Alessandro Carano | |||
| Annalisa Anastasia | |||
| Federica Vellante | |||
| Domenico De Berardis | |||
| Serena Di Natale | |||
| P2860 | cites work | Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine | Q24612175 |
| Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders | Q24811599 | ||
| Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review | Q26751363 | ||
| Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States | Q28469009 | ||
| Medicine and psychiatry in Western culture: Ancient Greek myths and modern prejudices | Q28750488 | ||
| How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments | Q30251969 | ||
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders | Q30583384 | ||
| Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets | Q31117436 | ||
| Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study | Q33774659 | ||
| Current nosology of treatment resistant depression: a controversy resistant to revision | Q33920910 | ||
| Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire | Q33923768 | ||
| Emergence of intense suicidal preoccupation during fluoxetine treatment | Q34033711 | ||
| Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports | Q34187358 | ||
| Is depression best viewed as a continuum or discrete category? A taxometric analysis of childhood and adolescent depression in a population-based sample | Q51933160 | ||
| Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis | Q52687120 | ||
| Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study | Q53281125 | ||
| Suicide risk during antidepressant treatment. | Q55041518 | ||
| The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications | Q58599247 | ||
| Reply to Dr. Gentili’ “Analysis of tolerance to antidepressant drugs in FDA Adverse Event Reporting System” | Q60441492 | ||
| Reply to Dr. Sharma’ “Understanding antidepressant tachyphylaxis” | Q60441494 | ||
| Effect of regulatory warnings on antidepressant prescribing for children and adolescents | Q80558017 | ||
| [Antidepressants and suicide -- did the FDA Black Box Warning back fire?] | Q86025889 | ||
| Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System | Q90615736 | ||
| Severe depression: is there a best approach? | Q34401712 | ||
| The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients | Q34446218 | ||
| Antidepressants and the risk of suicide in young persons – prescription trends and toxicological analyses | Q34470905 | ||
| Patient adherence in the treatment of depression | Q34514178 | ||
| Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries | Q34528374 | ||
| Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? | Q34623377 | ||
| Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database | Q35158151 | ||
| Persisting decline in depression treatment after FDA warnings | Q37504480 | ||
| Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs? | Q37958033 | ||
| The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? | Q38040453 | ||
| Contemporary Treatment Approaches to Major Depression and Bipolar Disorders | Q38845208 | ||
| Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment | Q38932319 | ||
| Monitoring of suicide risk throughout the course of treatment with antidepressants for depression is required, but vigilance is required for those on some particular antidepressant agents | Q40738322 | ||
| Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). | Q41168676 | ||
| Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients | Q44559177 | ||
| Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? | Q46435179 | ||
| Suicidality in pediatric patients treated with antidepressant drugs | Q46977975 | ||
| Understanding suicide risk within the Research Domain Criteria (RDoC) framework: A meta-analytic review | Q47235569 | ||
| Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents | Q47444850 | ||
| Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. | Q48075180 | ||
| The FDA warning on antidepressants and suicidality--why the controversy? | Q48184574 | ||
| Antidepressants' black-box warning--10 years later | Q48184586 | ||
| Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and "therapeutic sensation seeking" in response towards subjective intolerance to pain | Q48443289 | ||
| Beyond psychoanaleptics - can we improve antidepressant drug nomenclature? | Q48671505 | ||
| Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis | Q50020149 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | suicide risk | Q47319077 |
| P304 | page(s) | 294 | |
| P577 | publication date | 2019-05-03 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits? | |
| P478 | volume | 10 |
Search more.